S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
LON:OPTI

OptiBiotix Health (OPTI) Share Price, News & Analysis

GBX 18
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
17.76
18.09
50-Day Range
18
28
52-Week Range
5.57
43.50
Volume
31,051 shs
Average Volume
244,674 shs
Market Capitalization
£16.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OPTI stock logo

About OptiBiotix Health Stock (LON:OPTI)

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia, and diabetes. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.

OPTI Stock Price History

OPTI Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Best CBD Gummies For Sleep Of 2024
OptiBiotix Health Share Chat
OptiBiotix Health PLC OPTI
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Aetna Medicare Advantage Review (2023)
York Bio-tech firm reports record online sales
OptiBiotix Health
See More Headlines
Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/24/2020
Today
4/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Net Income
£-13,180,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.26 million
Cash Flow
GBX 2.07 per share
Book Value
GBX 10 per share

Miscellaneous

Free Float
N/A
Market Cap
£16.41 million
Optionable
Not Optionable
Beta
1.62
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Stephen Patrick O'Hara (Age 64)
    Founder, CEO & Executive Director
    Comp: $151k
  • Dr. Sofia Kolyda (Age 51)
    Executive Director of Research & Development and Executive Director
    Comp: $88k
  • Mr. Mark Kingsley Collingbourne (Age 58)
    CFO & Secretary
  • Paul Cannings
    Head of Operations & Quality
  • Kevin James Newman
    Corporate Development Director
  • Mr. Karl Burkitt
    Marketing Director

OPTI Stock Analysis - Frequently Asked Questions

How have OPTI shares performed in 2024?

OptiBiotix Health's stock was trading at GBX 26.75 at the beginning of the year. Since then, OPTI stock has decreased by 32.7% and is now trading at GBX 18.
View the best growth stocks for 2024 here
.

How were OptiBiotix Health's earnings last quarter?

OptiBiotix Health Plc (LON:OPTI) announced its earnings results on Thursday, September, 24th. The company reported ($0.70) earnings per share (EPS) for the quarter.

What other stocks do shareholders of OptiBiotix Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OptiBiotix Health investors own include Digital Globe Services (DGS), Derwent London (DLN), Oracle (ORCL), IQE (IQE), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE), Petrofac (PFC), Motif Bio (MTFB), Yamana Gold (YRI) and Agios Pharmaceuticals (AGIO).

How do I buy shares of OptiBiotix Health?

Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:OPTI) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners